A formal regulatory inspection of Canterbury-based mental health services has set out a series of recommended changes for Health New Zealand and is continuing checks over the next 12 months.

Medsafe has opened a consultation on proposals to reduce barriers to accessing clozapine, a medicine used to treat treatment-resistant schizophrenia.

This report is the result of an inspection of Canterbury – Waitaha adult inpatient and associated mental health services. The Director of Mental Health has powers under section 99 of the Mental Health ...